APOL1 and atherosclerosis: Apol‐I reduces inflammation by inhibiting the transendothelial migration of inflammatory cells and by reducing the expression of integrins, while ApoA‐II has been found to induce acute phase response in mice leading to accelerated atherosclerosis.28, 39